Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Statistics in Medicine|August 12, 1999
The impact of measurement error on the comparison of two treatments using a responder analysisL Oppenheimer, U KherBiochimica Et Biophysica Acta|February 3, 1992
Potentiation of epidermal growth factor receptor protein-tyrosine kinase activity by sulfateL Hubler, U Kher, P J BerticsJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Combined modality therapy for primary CNS lymphomaL M DeAngelis, J Yahalom, H T Thaler, et al.The Journal of Surgical Research|November 1, 1993
Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyteD Blumberg, M E Burt, U Kher, et al.Bone Marrow Transplantation|March 1, 1996
High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recoveryL B Faulkner, K L Lindsley, U Kher, et al.The American Journal of Medicine|November 1, 1996
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJ R Tucci, R P Tonino, R D Emkey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Pediatric desmoid tumor: retrospective analysis of 63 casesL B Faulkner, S I Hajdu, U Kher, et al.Proceedings of the Association of American Physicians|May 1, 1996
Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapyS L Greenspan, S Holland, L Maitland-Ramsey, et al.Cancer|January 1, 1994
Nativity, complications, and pathology are determinants of surgical results for gastric cancerJ G Fortner, G Y Lauwers, H T Thaler, et al.Cancer|July 15, 1994
Prognostic factors for recurrence and survival in head and neck soft tissue sarcomasD H Kraus, S Dubner, L B Harrison, et al.Pageof 2